19:51:09 EDT Tue 29 Apr 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

V:NGEN - Nervgen Pharma Corp. - https://www.nervgen.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NGEN - V  1.02.98·3.002.93.00+0.031.064.41811623.00  3.00  2.953.36  1.6515:59:59Apr 2115 min RT 2¢
TSX-V - V1.02.98·3.002.93.00+0.031.056.61611213.00  3.00  2.953.36  1.6515:59:5915 min
NEO ATS - U 3.00+0.031.02.36142.98  3.00  2.9615:35:2915 min
Pure - P 2.99+0.020.70.3132.96  2.99  2.9615:32:4915 min
Chi-X - X 3.00+0.031.01.53122.97  3.00  2.9615:35:2915 min
CXD - D 2.970.022    Apr 2415 min
TriAct - M 2.970.418    Sep 04/2015 min
Lynx - Y 2.98+0.010.33.41022.98  2.98  2.9812:50:1715 min

Recent Trades - Last 10 of 162
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:59V3.000.0310079 CIBC1 AnonymousK
15:59:59V3.000.0310079 CIBC1 AnonymousK
15:59:59M3.000.037314 Virtu ITG2 RBCE
15:59:48V3.000.0310080 National Bank1 AnonymousK
15:59:48V3.000.0256753 Morgan Stanley80 National Bank
15:59:29V2.9950.0251001 Anonymous79 CIBCK
15:57:18V3.000.0310079 CIBC1 AnonymousK
15:56:39V3.000.0310053 Morgan Stanley1 AnonymousK
15:55:00V3.000.0310053 Morgan Stanley1 AnonymousK
15:50:46V3.000.0310053 Morgan Stanley1 AnonymousK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-04-21 07:31C:NGEN2.96News ReleaseNervGen Pharma to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
2025-04-14 21:03C:NGEN2.94Prospectus ApprovedNervgen Pharma prospectus offering
2025-04-09 19:29C:NGEN2.87News ReleaseNervgen issues 564,500 shares under ATM program in Q1
2025-04-03 07:43C:NGEN3.30SEDAR MD & ASEDAR MD & A
2025-04-03 07:38C:NGEN3.30SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-04-03 07:31C:NGEN3.30News ReleaseNervGen Pharma Reports 2024 Year-End Financial Results and Provides Business Updates
2025-03-31 18:47C:NGEN2.87News ReleaseNervgen starts expanded access policy for NVG-291
2025-03-25 17:15C:NGEN2.65News ReleaseNervgen Pharma to hold virtual investor event April 9
2025-03-14 19:32C:NGEN2.72News ReleaseNervgen Pharma grants options to buy 545,000 shares
2025-02-18 19:46C:NGEN2.97News ReleaseNervgen Pharma grants options to buy 627,200 shares
2025-02-06 16:54C:NGEN2.86News ReleaseNervgen doses subject in phase 1b/2a NVG-291 trial
2025-01-02 16:41C:NGEN3.32News ReleaseNervgen enrolls final chronic subject in NVG-291 trial
2024-12-20 16:25C:NGEN3.00News ReleaseNervgen Pharma arranges ATM equity program
2024-11-14 08:31C:NGEN2.68News ReleaseNervGen Pharma Reports Q3 2024 Financial Results and Operational Updates
2024-11-14 08:05C:NGEN2.68SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-11-14 08:05C:NGEN2.68SEDAR Interim MD & ASEDAR Interim MD & A
2024-11-07 08:31C:NGEN2.52News ReleaseNervGen Pharma to Present at the Stifel 2024 Healthcare Conference
2024-11-04 19:29C:NGENSEDAR Final Short Form ProspectusSEDAR Final Short Form Prospectus
2024-11-04 13:45C:NGEN2.59SEDAR Preliminary Short Form ProspectusSEDAR Preliminary Short Form Prospectus
2024-10-28 15:53C:NGEN2.60SEDAR Annual Information FormSEDAR Annual Information Form